mad2 protein (OriGene)
Structured Review

Mad2 Protein, supplied by OriGene, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mad2 protein/product/OriGene
Average 90 stars, based on 1 article reviews
Images
1) Product Images from "The HuR CMLD-2 inhibitor exhibits antitumor effects via MAD2 downregulation in thyroid cancer cells"
Article Title: The HuR CMLD-2 inhibitor exhibits antitumor effects via MAD2 downregulation in thyroid cancer cells
Journal: Scientific Reports
doi: 10.1038/s41598-019-43894-0
Figure Legend Snippet: CMLD-2 effects on MAD2 protein levels in thyroid cancer cells. Panel A. MAD2 is identified as HuR target by RIP assay. Thyroid cancer cells were lysed and immunoprecipitated with anti-HuR or anti-IgG antibodies. HuR–bound mRNAs were amplified using specific MAD2 and MARCH3 (negative control) primers and analyzed by qPCR. All samples were run in triplicate. IgG-immunoprecipitate was arbitrarily set at 1.0 and the enrichment was expressed as relative expression value (Fold Enrichment). Panel B. SW1736, 8505 C, BCPAP and K1 cells were treated with DMSO or CMLD-2 35 µM for 72 h. Cells were collected and MAD2 protein levels were analyzed by Western Blot. Panel C. Densitometric analysis of MAD2 protein levels obtained with Western Blot assay. For each cell line, the results were normalized against Actin and expressed as percentage over control. Results are shown as mean ± SD. ***p < 0.001, ****p < 0.0001 by Student’s t-test.
Techniques Used: Immunoprecipitation, Amplification, Negative Control, Expressing, Western Blot
Figure Legend Snippet: Biological effects of MAD2 silencing in thyroid cancer cells. 8505 C and BCPAP cells were transfected with vehicle (mock), non-targeting siRNA (NC, negative control) or three different siRNA (#1, #2 and #3) sequence specific to MAD2 (5 nM) for 72 h and cell viability was analyzed by MTT assay. All experiments were run in sixfold. P < 0.05, **P < 0.001, ***P < 0.0001 by Student’s t-test.
Techniques Used: Transfection, Negative Control, Sequencing, MTT Assay
Figure Legend Snippet: MAD2 is involved in CMLD-2 effects in thyroid cancer cell lines. Panel A. 8505 C and BCPAP cells were treated with DMSO, CMLD-2, pCMV empty vector (NC, negative control), pCMV vector specific for MAD2 (1.3 µg), alone or in combinations. Cells were collected after 72 h treatment and MAD2 protein levels were analyzed by Western Blot. Panel B. 8505 C and BCPAP cells were treated with DMSO, CMLD-2, pCMV empty vector (NC, negative control), pCMV vector specific for MAD2 (1.3 µg), alone or in combinations and cell viability was determined by MTT assay after 72 h. NC was arbitrarily set at 1 and cell viability was expressed as relative expression value. All samples were run in sixfold. P < 0.05, **P < 0.001, ***P < 0.0001 by Student’s t-test.
Techniques Used: Plasmid Preparation, Negative Control, Western Blot, MTT Assay, Expressing


![(A) A schematic map of human p31 comet deletion mutants of the N- and C-termini, and regions affecting <t>Mad2</t> binding and nuclear localization signal (NLS). (B) HeLa cells were infected with retroviruses containing full-length p31 comet or the above deletion constructs and evaluated in terms of colony formation. GFP+ signifies colonies expressing p31 comet . The total represents the sum of GFP-positive and -negative colonies. Values are presented as the mean of triplicate samples. (C) Interactions between p31 comet deletion mutants and Mad2 were evaluated using an immunoprecipitation assay. Lysates from cells co-transfected with FLAG-tagged wild-type or deletion constructs of p31 comet and Myc-tagged Mad2 were immunoprecipitated with an anti-FLAG antibody, and the resulting immunoprecipitates probed with an anti-Myc antibody. Expression of recombinant proteins was confirmed using antibodies directed against FLAG or Myc.]](https://pub-med-central-images-cdn.bioz.com/pub_med_central_ids_ending_with_6321/pmc04636321/pmc04636321__pone.0141523.g002.jpg)